Skip to Main Content

Author Details

Joellen M Schildkraut
Rollins School of Public Health, Emory University
1988
375
70
PMIDPaper TitleJournal TitlePublished Year
36826816Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility.JAMA Netw Open2023
37865688Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium.Br J Cancer2023
38014246<i>Cis</i>- and <i>trans</i>-eQTL TWAS of breast and ovarian cancer identify more than 100 risk associated genes in the BCAC and OCAC consortia.bioRxiv2023
37961178Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms.bioRxiv2023
37835542The Association between Mediated Deprivation and Ovarian Cancer Survival among African American Women.Cancers (Basel)2023
37873386The tumor multi-omic landscape of endometrial cancers developed on a germline genetic background of adiposity.medRxiv2023
37537254Association of inflammation-related exposures and ovarian cancer survival in a multi-site cohort study of Black women.Br J Cancer2023
37159277Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer.Obstet Gynecol2023
37423270Deprivation and segregation in ovarian cancer survival among African American women: a mediation analysis.Ann Epidemiol2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37115922The genomic landscape of familial glioma.Sci Adv2023
37409955Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility.Cancer Epidemiol Biomarkers Prev2023
36520244Survival of epithelial ovarian cancer in Black women: a society to cell approach in the African American cancer epidemiology study (AACES).Cancer Causes Control2023
36401943Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.Gynecol Oncol2023
36688720Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.J Natl Cancer Inst2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
34776242Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.Gynecol Oncol2022
35654411Race Differences in the Associations between Menstrual Cycle Characteristics and Epithelial Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2022
35702670Pleiotropic <i>MLLT10</i> variation confers risk of meningioma and estrogen-mediated cancers.Neurooncol Adv2022
35633315Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium.Int J Cancer2022
35454861CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.Cancers (Basel)2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
36138071Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium.Br J Cancer2022
35867953Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia.J Clin Oncol2022
36222710Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Clin Cancer Res2022
34882782Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study.Cancer2022
35244678Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma.Cancer Epidemiol Biomarkers Prev2022
35064059Reproductive Factors Do Not Influence Survival with Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2022
35235563Tumor immune cell clustering and its association with survival in African American women with ovarian cancer.PLoS Comput Biol2022
34789471High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2022
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
33521947First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women.Int J Cancer2021
33619020Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.Cancer Epidemiol Biomarkers Prev2021
34438316Increasing Area Deprivation Index negatively impacts ovarian cancer survival.Cancer Epidemiol2021
34155063Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium.Cancer Epidemiol Biomarkers Prev2021
34204319Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data.Cancers (Basel)2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
33246661Genetically predicted circulating protein biomarkers and ovarian cancer risk.Gynecol Oncol2021
32766851Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies.J Natl Cancer Inst2021
30963577Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.Int J Cancer2020
31845738Invited Commentary: Relationship Between Ovulation and Markers of Systemic Inflammation Versus Markers of Localized Inflammation.Am J Epidemiol2020
31665421Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis.Neuro Oncol2020
32959149Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.Eur J Epidemiol2020
32620889Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.Nat Commun2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32362566Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES).Gynecol Oncol2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32241384Racial/ethnic disparities in ovarian cancer research.Adv Cancer Res2020
32239218Association Between Breastfeeding and Ovarian Cancer Risk.JAMA Oncol2020
31469419Identification of novel epithelial ovarian cancer loci in women of African ancestry.Int J Cancer2020
  • 1 - 50 of 375

Recommended Authors

Eloise Chapman-Davis
Weill Cornell Medical College
Career Start Year 2009
Number of shared co-authors 0
Hui-Chun Irene Su
University of California San Diego
Career Start Year 2008
Number of shared co-authors 2
Hisani N Horne
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 31
Camille Ragin
Fox Chase Cancer Center
Career Start Year 2004
Number of shared co-authors 13
Katherine D Crew
Columbia University Irving Medical Center
Career Start Year 2004
Number of shared co-authors 5
Jenny N Poynter
University of Minnesota
Career Start Year 2004
Number of shared co-authors 22
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 21
Amit Arora
University of Arizona
Career Start Year 2003
Number of shared co-authors 3
Neeraja B Peterson
Vanderbilt University Medical Center
Career Start Year 2003
Number of shared co-authors 9
Jessica M Faupel-Badger
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 9
Jeanine M Genkinger
Mailman School of Public Health, Columbia University
Career Start Year 2001
Number of shared co-authors 23
Elad Ziv
Institute for Human Genetics, University of California San Francisco (UCSF)
Career Start Year 2001
Number of shared co-authors 91
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 34
Reina Haque
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 3
Dina N Paltoo
National Institutes of Health
Career Start Year 1998
Number of shared co-authors 14
Roberta McKean-Cowdin
Keck School of Medicine, University of Southern California
Career Start Year 1998
Number of shared co-authors 74
Rick A Kittles
Morehouse School of Medicine
Career Start Year 1998
Number of shared co-authors 57
Simone Maistro
Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo
Career Start Year 1994
Number of shared co-authors 0
Lisa Madlensky
Department of Medicine and Moores Cancer Center, University of California San Diego.
Career Start Year 1994
Number of shared co-authors 12
Carmen Rodriguez
Institut de Recherche en Cancerologie de Montpellier
Career Start Year 1993
Number of shared co-authors 23
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 13
Ernst Lengyel
University of Chicago
Career Start Year 1993
Number of shared co-authors 31
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 11
Ruth M Pfeiffer
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 45
Jeffery P Struewing
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 46
David Tritchler
University at Buffalo
Career Start Year 1984
Number of shared co-authors 8
Dennis Deapen
Keck School of Medicine, University of Southern California
Career Start Year 1981
Number of shared co-authors 16
Thomas E Rohan
Albert Einstein College of Medicine
Career Start Year 1980
Number of shared co-authors 57
Graham A Colditz
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 73
Sholom Wacholder
National Cancer Institute
Career Start Year 1977
Number of shared co-authors 49

Collaborators

Andrew Berchuck
Duke School of Medicine
Co-authored papers 164
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 124
Anna H Wu
University of Southern California
Co-authored papers 112
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 111
Elisa V Bandera
Co-authored papers 110
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 108
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 107
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 104
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 101
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 101
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 96
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 87
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 87
Hoda Anton-Culver
University of California irvine
Co-authored papers 85
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 85
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 80
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 80
Honglin Song
University of Cambridge
Co-authored papers 78
Alice S Whittemore
Co-authored papers 76
Patricia G Moorman
Co-authored papers 76
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 73
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 73
Weiva Sieh
Co-authored papers 63
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 62
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 59
Jill S Barnholtz-Sloan
National Cancer Institute
Co-authored papers 59
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 58
Jonathan Tyrer
Co-authored papers 57
Pamela J Thompson
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 56
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 53
Release 1.2